CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Genmel Technology has created TinniMizer, a patented musical therapy system designed to treat tinnitus. This innovative approach aims to significantly reduce tinnitus symptoms in patients within a shorter treatment duration.
Tinnitus can be a debilitating condition, which negatively affects a patient’s overall health and social well-being.
Even moderate cases can interfere with the ability to work and socialise.
The financial consequences of tinnitus are significant.
Personal economic loss to an individual with tinnitus--including lost earnings, productivity, and health expenses--can be up to €30,000 annually.
The cost to society as a whole has been estimated at upwards of €26 billion annually.
Despite these effects…
GENMEL BIYOMEDIKAL TEKNOLOJI ARGE SANAYI VE TICARET LIMITED SIRKETI
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
